Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3488323016 | Product containing afatinib (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3713014013 | Afatinib-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Afatinib-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Afatinib-containing product | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Afatinib-containing product | Is a | Protein-tyrosine kinase inhibitor-containing product | true | Inferred relationship | Some | ||
| Afatinib-containing product | Has active ingredient | Afatinib | true | Inferred relationship | Some | 1 | |
| Afatinib-containing product | Is a | Medicinal product categorised by structure | false | Inferred relationship | Some | ||
| Afatinib-containing product | Is a | Enzyme inhibitor-containing product | false | Inferred relationship | Some | ||
| Afatinib-containing product | Is a | Quinazoline-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Afatinib only product | Is a | True | Afatinib-containing product | Inferred relationship | Some | |
| Afatinib dimaleate 20 mg oral tablet | Is a | False | Afatinib-containing product | Inferred relationship | Some | |
| Afatinib dimaleate 30 mg oral tablet | Is a | False | Afatinib-containing product | Inferred relationship | Some | |
| Afatinib dimaleate 40 mg oral tablet | Is a | False | Afatinib-containing product | Inferred relationship | Some | |
| Afatinib-containing product in oral dose form | Is a | True | Afatinib-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR